Detalles de la búsqueda
1.
Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach.
Biol Res
; 57(1): 21, 2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704600
2.
Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review.
Urol Int
; 108(3): 198-210, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310863
3.
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
BMC Cancer
; 22(1): 375, 2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35395766
4.
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis.
Eur J Nucl Med Mol Imaging
; 48(4): 1200-1210, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970216
5.
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry.
Future Oncol
; 17(18): 2325-2338, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33724867
6.
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis.
Eur J Nucl Med Mol Imaging
; 47(9): 2106-2112, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062682
7.
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry.
Future Oncol
; 16(35): 2939-2948, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021843
8.
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone.
Int J Mol Sci
; 18(2)2017 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28208664
9.
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer.
Int J Mol Sci
; 17(9)2016 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27618028
10.
[Emergencies in cancer immunotherapy]. / Notfälle in der Medikamentösen Tumortherapie.
Aktuelle Urol
; 55(1): 28-37, 2024 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-37607581
11.
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy.
Eur Urol Oncol
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38866640
12.
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
J Clin Oncol
; : JCO2301983, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657187
13.
[Perioperative systemic treatment of urothelial cancer]. / Perioperative Systemtherapie des Urothelkarzinoms.
Urologie
; 62(4): 407-417, 2023 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-36856789
14.
Immunohistochemical expression of TROP2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer.
Oncol Lett
; 26(6): 527, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38020299
15.
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer.
Biomark Res
; 11(1): 37, 2023 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016463
16.
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort.
Eur Urol Open Sci
; 53: 31-37, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441344
17.
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
Clin Cancer Res
; 29(8): 1496-1505, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36534531
18.
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients.
Sci Rep
; 12(1): 11846, 2022 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35831403
19.
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives.
Cancers (Basel)
; 13(15)2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359614
20.
Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registry.
Transl Androl Urol
; 10(10): 4062-4074, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804848